Experts say it’s too soon to know for sure what the coronavirus will do next, but one thing is clear: the world is going to have to live with COVID-19.
Author: Karen Weintraub, USA TODAY
First-ever pig-to-human heart transplant offers hope for thousands in need of organs
The breakthrough by doctors at the University of Maryland offers hope for those who languish on organ transplant waitlists.
Baby Fitz was born without an immune system. His treatment offers hope for curing rare diseases.
in the coming years, scientists hope to end a number of illnesses that have caused misery for generations.
50 years after the US declared war against cancer, the fight continues. These are the 10 biggest victories.
The National Cancer Act’s 50th anniversary offers the chance to reflect on the Top 10 improvements in care.
New COVID treatments are coming. Will they help combat the omicron onslaught?
New antiviral COVID-19 treatments are coming but getting enough supply to fight the omicron variant surge is a concern.
Could treatments for rare diseases be found in neighborhood pharmacies? New uses for old drugs offer promise
For patients with extremely rare diseases, repurposing existing drugs may be their only hope.
A year after first COVID-19 vaccine, here’s what’s next for researchers – and what worries them
A year after the first COVID-19 vaccines were administered in the U.S., what do researchers have their sights set on? Perhaps, a future without shots.
‘Our best defense’: Pfizer says third dose of its COVID vaccine protects against omicron
A third dose of the Pfizer-BioNTech vaccine appears to be as effective against omicron as two doses were against the original variant.
FDA panel narrowly recommends authorization of first antiviral to treat COVID-19
The drug, molnupiravir from Merck, is intended to be used in people at risk for severe COVID-19. The FDA panel authorized its use by a vote of 13-10.
CDC makes COVID vaccine boosters available for all US adults, recommends for 50 and older
CDC Director Dr. Rochelle Walensky signed off on the advisory panel’s recommendations on Friday night, making them federal policy.